← Product Code [FMI](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMI) · K062608 # 29G AND 30G K-PACK II NEEDLE (K062608) _Terumo Europe N.V. · FMI · Sep 15, 2006 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMI/K062608 ## Device Facts - **Applicant:** Terumo Europe N.V. - **Product Code:** [FMI](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMI.md) - **Decision Date:** Sep 15, 2006 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 880.5570 - **Device Class:** Class 2 - **Review Panel:** General Hospital - **Attributes:** Therapeutic ## Indications for Use The 29 Gauge & 30 Gauge K-Pack II Needle being Hypodermic Single Lumen Needles are sterile medical devices for single use, intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. ## Device Story Sterile, single-use hypodermic needle; consists of stainless steel tube sharpened at one end and attached to polypropylene female luer hub. Designed for connection to male nozzle of piston syringe. Used by clinicians to inject or withdraw fluids below skin surface. Provides standard hypodermic access; smaller gauge (29G/30G) allows for thinner needle profile compared to predicate. Benefits patient via minimally invasive fluid delivery or sampling. ## Clinical Evidence No clinical data. Bench testing only. Biocompatibility testing performed per ISO 10993; sterilization validation performed per EN 550/ISO 11135; EtO residuals compliant with EN ISO 10993-7. ## Technological Characteristics Stainless steel needle tube; polypropylene hub. Externally communicating, circulating blood, limited exposure (<24 hrs). Sterilized via ethylene oxide (EtO) per EN 550/ISO 11135. Biocompatibility per ISO 10993. ## Regulatory Identification A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set. ## Predicate Devices - K-Pack II Needles ([K984576](/device/K984576.md)) - Neolus Needles ([K001572](/device/K001572.md)) - TERUMO 30 Gauge Hypodermic Needle ([K012646](/device/K012646.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K062608 # 510(k) SUMMARY as required by 807.92 Summary of Safety & Effectiveness Information - 1. Device Name # Proprietary Name SEP 1 5 2006 29 Gauge & 30 Gauge K-Pack II Needle Classification Name Hypodermic Single Lumen Needle 21CFR, Section 880.5570 Classification: Class II 2. Reason for Submission > This 510k is being submitted to extend the cleared K-Pack II Needle (K984576) product line. The size of the 29 Gauge needle and the 30 Gauge needle is smaller than what is currently cleared under the current K-Pack II Needle 510k (K984576). This Special 510k is being submitted because of potential issues of safety and effectiveness specific for a smaller/thinner needle. This 510k will provide supporting information that the 29 Gauge & 30 Gauge K -Pack II Needles are safe and effective and an acceptable extension of the current K-Pack II Needle product line. #### 3. Intended Use The 29 Gauge & 30 Gauge K-Pack II Needle being Hypodermic Single Lumen Needles are sterile medical devices for single use, intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. Note: This is the same intended use as the predicate device, K-Pack II Needle - K984576. #### 4. Description The 29 Gauge or 30 Gauge K-Pack II Needle is a sterile hypodermic single lumen needle, for single use consisting of a stainless steel tube that is sharpened at one end and at the other end joined to a female luer connector (hub) made of polypropylene designed to be connected with a male connector (nozzle) of a piston syringe. {1}------------------------------------------------ - 5. Substantial Equivalence The 29 Gauge and 30 Gauge K-Pack II Needles are substantially equivalent in intended use, design, technology/principal of operation, materials, and performance to the following cleared devices: - I . K-Pack II Needles (K984576) - 2. Neolus Needles (K001572) - TERUMO 30 Gauge Hypodermic Needle (K012646) 3. Differences between the devices do not raise any significant issues of safety and effectiveness. #### 6. Additional Safety Information The sterility of the 29 Gauge and 30 Gauge K-Pack II Needles is assured by using a validated sterilization method qualified in accordance with EN 550: "Sterilization of Medical Devices: Validation and routine control of ethylene oxide" and ISO 11135: "Medical Devices: Validation and routine control of ethylene oxide sterilization" to a sterility assurance level (SAL) of 100 as required by EN 556-1: "Sterilization of Medical Devices - Requirements for medical devices to be designated "STERILE" - Part - 1: Requirements for terminally sterilized medical devices". Ethylene oxide residual levels resulting from EtO sterilization are in compliance with EN ISO 10993-7: " Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals" The 29 Gauge & 30 Gauge K-Pack II Needle, like the standard K-Pack II Needle (K984576), is an Externally Communicating device, Circulating Blood, Limited Exposure (24 hrs). The device's blood contacting materials were tested in accordance with the tests recommended in the FDA General Program Memorandum #G95-1 (5/1/95): Use of International Standard ISO-10993, "Biological Evaluation of Medical Devices Part-1: Evaluation and testing". The expiration dating for the 29 Gauge & 30 Gauge K-Pack II Needle has been established at 5 years which is the same as the cleared K-Pack II Needles. #### 7. Conclusion In summary, the 29 Gauge & 30 Gauge K-Pack II Needles are substantially equivalent in intended use, design, technology/principal of operation, materials, and performance to the following cleared devices: - 1. K-Pack II Needles (K984576) - 2. Neolus Needles (K001572) - 3. TERUMO 30 Gauge Hypodermic Needle (K012646) Differences between the devices do not raise any new issues of safety or effectiveness. {2}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines forming its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle. ### Public Health Service SEP 1 5 2006 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mrs. M. J. Aerts Manager Regulatory Affairs Terumo Europe N.V. Researchpark Zone 2 Haasrode Interleuvenlaan 40 B-3001 LEUVEN-BELGIUM Re: K062608 Trade/Device Name: 29 Gauge and 30 Gauge K-Pack II Needle Regulation Number: 21 CFR 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: II Product Code: FMI Dated: August 31, 2006 Received: September 5, 2006 Dear Mrs. Aerts: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice. labeling, and prohibitions against misbranding and adultcration. If vour device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ ### Page 2 - Mrs. Aerts Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely vours. Chih-Lin, Ph.D. Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use K 0626 510(k) Number (if known): Device Name: 29 Gauge and 30 Gauge K-Pack II needle Indications for Use: The K-Pack II needle being a Hypodermic Single Lumen Needle is a sterile medical device for single use, intended to inject fluids into, or withdraw fluids from parts of the body below the surface of the skin. Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Page of Cuth D. V. Jun Sign-Cff) on of Anesthesiology, General Hospital, Jion Control, Dental Devices in ber --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMI/K062608](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMI/K062608) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com